Medable Stock
| Valuation | $2.1B1 |
| Valuation Date | Oct 26, 2021 |
| Implied Valuation | n/a |
| Last Price | $3.00 |
| 52-Week High | $3.00 |
| 52-Week Low | $3.00 |
| YTD Return | +0.00% |
| 1-Year Return | +0.00% |
| 3-Year Return | n/a |
| Total Funding | $521M1 |
| Latest Round Amount | $304M1 |
| Latest Round | Series D |
| Funding Rounds | 7 |
| IPO Status | Unknown |
| Expected IPO Date | n/a |
| Revenue | n/a |
| Revenue Type | n/a |
| P/S Ratio | n/a |
About Medable
Medable is a clinical development software company that sells a cloud platform for digital and decentralized clinical trials. Its tools cover electronic clinical outcome assessments, eConsent, televisits and connected sensors so sponsors can enroll and run studies without requiring every visit at a research site. The company has more recently added Agent Studio, a no-code product that lets clinical teams deploy GxP-ready AI agents for trial monitoring, trial master file documents and protocol data. Medable makes money by selling software subscriptions to pharmaceutical companies, biotech firms and contract research organizations, including SaaS contracts that cover a whole trial portfolio rather than a single study.
Invest in Medable
Medable is a private company, so you can't purchase it with a regular brokerage account. However, its shares are available on Clarity (formerly Hiive).
Clarity is a secondary marketplace where accredited investors can buy and sell shares of private, pre-IPO companies. Invest in the world's most exciting startups before they go public.
Invest on ClarityStock Analysis may be compensated for user sign-ups through Clarity links. Clarity is not affiliated with Stock Analysis. Securities offered by Clarity Capital Limited, member of FINRA/SIPC.
News
MRCT Center and Medable Launch New Resources for Investigator Oversight in Decentralized Clinical Trials
Medable and the MRCT Center released new tools to help sponsors and investigators maintain oversight when running decentralized clinical trials.
Medable Launches The Industry's First Agentic AI Platform and CRA Agent
Medable introduced Agent Studio, a no-code agentic AI platform for life sciences, along with CRA Agent for clinical trial monitoring to automate routine workflows with human oversight.
Medable and ICON Exceed Patient eConsent Adoption Goals for Women's Health Study on Menopause
Medable reported that more than 85% of participants in a U.S. menopause study managed by ICON used its Total Consent eConsent technology, with 18 sites reaching 100% adoption.
New Tufts CSDD Analysis Finds AI Agents Can Deliver Up to $21 Million in Net Financial Value Per Drug Development Program
Medable and Tufts CSDD reported that an AI clinical monitoring agent could deliver up to $21 million in net present value per phase 3 oncology program and an estimated 82x return on investment.
Medable Introduces Digital Data Flow Agent, Laying the Foundation for End-to-End Agentic Clinical Development
PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., the leading technology platform for agentic clinical development, today announced its Digital Data Flow (DDF) Agent, which automatically transforms st...
Medable Launches Agentic Accelerator Program to Help Life Sciences Companies Deploy Agentic AI Across Clinical Development Lifecycle
Medable launched a program that helps sponsors and CROs roll out its Agent Studio tools, with onboarding, integration support and change management. The company said the offer is available to all Agen...
Medable CEO Michelle Longmire Featured as Guest Speaker with Leaders from Google and Mayo Clinic at Japan's Largest Pharmaceutical Summit
Medable said CEO and co-founder Michelle Longmire would speak at Japan's Ubie Pharma Summit alongside speakers from Google for Health and Mayo Clinic Platform. The appearance was billed as part of the...
Medable Introduces AI Agent to Reduce Burden at Research Sites by Assisting Principal Investigators with Oversight of eCOA Data
Medable launched a PI Summary Agent that monitors eCOA participant data and gives investigators an AI-generated summary with human-in-the-loop control. It followed the company's TMF and CRA agents on ...
Medable Debuts AI Agent for Automating Trial Master File (TMF) Processes
Medable introduced a TMF Agent that classifies trial documents, extracts metadata and prepares them for review before submission into eTMF systems such as Veeva Vault. CEO Michelle Longmire was also s...
Medable Named a Leader Amid Growing eCOA Adoption
Medable said Everest Group named it a Leader in the 2025 Life Sciences eCOA Products PEAK Matrix Assessment. The company pointed to AI features, multimodal data capture and pricing as reasons buyers c...
.webp)
Medable Launches The Industry's First Agentic AI Platform and CRA Agent; Removes Bottlenecks in Clinical Development
Medable launched Agent Studio, a no-code builder for clinical-development AI agents, along with a CRA Agent for trial monitoring. The company said the tools keep a human in the loop and connect to sys...
Medable Launches Partner Program for Faster Clinical Trial Startup, Greater Control, and Transparent Pricing
Medable opened a partner program that lets CROs build eCOA studies on its platform with self-service tools and up-front pricing. The company said the program is meant to cut trial startup timelines.
Medable Reports 80% Revenue Growth from Portfolio-Level eCOA Adoption, Sharp Increase Compared to Study-by-Study Adoption
Medable said 2024 revenue from enterprise customers on portfolio-level eCOA SaaS contracts grew 80% versus study-by-study deals. It did not disclose a dollar revenue figure.
Medable Joins Forces with Google Cloud to Deliver Digital Clinical Trials Technology on Google Cloud Marketplace
Medable put its digital clinical-trial platform, including Medable Studio, on Google Cloud Marketplace. Customers can pay for usage on Google Cloud invoices.
New Medable Studio Empowers Sponsors to Launch eCOA Solutions into Clinical Trials with Unparalleled Control and Efficiency
Medable launched Studio, a no-code application for configuring, translating and launching eCOA, eConsent, televisits and sensors. Co-founder and CTO Tim Smith said it is meant to cut study-build timel...
Medable and Masimo Partner to Bring Best-in-Class Wearable Devices to Clinical Research, Capturing Rich Subjective and Objective Data
PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., the leading technology provider for modern clinical trials, is partnering with industry leader Masimo (NASDAQ: MASI) to bring best-in-class medical-gr...
Syneos Health Extends Partnership with Medable
Continued Collaboration Will Accelerate Bringing Clinical Trials Closer to the Patient Continued Collaboration Will Accelerate Bringing Clinical Trials Closer to the Patient
Medable and CVS Health Announce Collaboration to Expand Clinical Trial Access
PALO ALTO, Calif.--(BUSINESS WIRE)-- #access--Medable and CVS Health announced a collaboration to expand clinical trial access via select MinuteClinic™ locations using Medable's software platform.
Medable Acquires Mobile Applications from LEO Pharma, Expands Global Engineering Team and European Presence
Medable acquired Omhu A/S from LEO Innovation Lab, taking over the Danish digital-health team's mobile apps and 38 employees. Terms were not disclosed.
Medable Secures $304 Million in Funding at $2.1 Billion Valuation; New Round Co-Led by Blackstone Growth, GSR Ventures and Tiger Global
PALO ALTO, Calif.--(BUSINESS WIRE)-- #biotech--Medable secured $304 million in Series D funding at $2.1 billion valuation to accelerate global adoption of digital and decentralized clinical trials.
Medable Secures Another $78 Million Funding to Fuel Digital Innovation for Patient-Centered Drug Development
PALO ALTO, Calif.--(BUSINESS WIRE)-- #biotech--Medable announced $78 million in new funding to fuel advances in the delivery of decentralized clinical trials and patient-centered research.
Medable Secures $91 Million Funding to Accelerate Industry Shift to Digital and Decentralized Clinical Trials
Medable raised $91 million in Series C funding led by Sapphire Ventures, with GSR Ventures, PPD and Streamlined Ventures participating. The company said the round brought total capital raised to more ...
Medable Secures $25M Venture Funding to Drive Global Adoption of Decentralized Clinical Trials
Medable raised $25 million led by GSR Ventures, with existing investor PPD participating. The company said the round brought total capital raised to more than $45 million.